Although C-reactive protein (CRP) has been widely used for many years as an inflammatory biomarker to assess disease activity in patients with IBD, it has low sensitivity and specificity in detecting bowel inflammation [8, 9]. This evidence concerns the gene CRP and inflammatory bowel disease.